Where the Biotech Bets Are
Where the Biotech Bets Are John McCamant of The Medical Technology Stock Letter tells where he’s making his in this poorly performing sector.
Get email updates
Get new actionable insights and updates from BiotechBlog
Where the Biotech Bets Are John McCamant of The Medical Technology Stock Letter tells where he’s making his in this poorly performing sector.
Biotech lobbyists’ clout grows in Washington The Biotechnology Industry Organization is still unpacking from its move into a bigger office a few blocks from the White House, underscoring the outfit’s rapid climb to lobbying juggernaut status.
Get new actionable insights and updates from BiotechBlog